Align Technology (NASDAQ:ALGN) Cut to Neutral at UBS Group
UBS Group downgraded shares of Align Technology (NASDAQ:ALGN – Free Report) from a buy rating to a neutral rating in a research note published on Friday morning, MarketBeat.com reports. The firm currently has $200.00 price objective on the medical equipment provider’s stock. Several other research analysts have also weighed in on the company. Jefferies Financial […]